Effect of Vernonia Cinerea Lozenges as a Smoking Cessation Aid in Patients With Non-communicable Diseases
NCT ID: NCT06268002
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
93 participants
INTERVENTIONAL
2017-09-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Multicenter Observational Study on Safety of the Herbal Medicines at Inpatient Setting
NCT04269486
Effect of Thyme Oil on Respiratory Symptoms and Hemodynamic Parameters in COPD Patients
NCT06156449
Clinical Application and Basic Study of Medicinal Fractions-based Herbal Combinations
NCT01636154
Evaluation of the Safety and Clinical Efficacy of NRICM102 in Patients With Chronic Lower Respiratory Tract Diseases
NCT06690203
Effectiveness of Chinese Herbal Therapy for Asthma
NCT00712296
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vernonia cinerea group
1 lozenges 3 times per day
Vernonia cinerea
Vernonia cinerea is an herb that is claimed in many Thai medicinal formulas. In traditional medicines, they use this herbal to treat diseases such as hypertension, asthma, fever, hepatitis, gallstones, including use to help smoker quit smoking.
Placebo group
1 placebo lozenges 3 times per day
Placebo
Sweetener
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vernonia cinerea
Vernonia cinerea is an herb that is claimed in many Thai medicinal formulas. In traditional medicines, they use this herbal to treat diseases such as hypertension, asthma, fever, hepatitis, gallstones, including use to help smoker quit smoking.
Placebo
Sweetener
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have at least 1 underlying non-communicable disease include hypertension, diabetes, dyslipidemia, cardiovascular diseases, cerebrovascular diseases, stable asthma (defined as no asthmatic exacerbation for the preceding 4 weeks necessitating oral prednisolone or an increased use of inhaled corticosteroid, the use of rescue treatment no more than three times a week, and with no clinical indication for change in treatment medication) COPD stage A-C according to GOLD guideline, chronic kidney diseases
* Smoke 10 cigarettes or over per day at least 1 month prior to study
* Desired to quit smoking
* Consent to participate in study
Exclusion Criteria
* Liver dysfunction (Child-Pugh score C)
* Hyperkalemia (serum potassium ≥ 5 mEq/L)
* Documented of active depression or psychosis
* Active cancer
* History of acute coronary syndrome in previous 4 weeks
* Known case of pregnancy or lactation
* Use other tobacco products or other addictive substances except alcohol
* Use other smoking cessation drugs
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chulalongkorn University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Krittin Bunditanukul
Bangkok, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
5876557033
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.